Skip to main content

Table 2 Clinicopathological parameters of the malignant cases

From: The role of FoxP3+ regulatory T cells and IDO+ immune and tumor cells in malignant melanoma – an immunohistochemical study

Variable

pT1

pT4

pN1

Total

Number of cases

31 (30.7%)

36 (35.6%)

34 (33.7%)

101 (100%)

Age

 Mean ± SD

60.8 ± 11.8

64.8 ± 16.2

51.71 ± 17.0

59.2 ± 16.1

 Range

35–81

15–92

5–83

5–92

Sex

 Female

16 (15.8%)

13 (12.9%)

15 (14.9%)

44 (43.6%)

 Male

15 (14.9%)

23 (22.8%)

19 (18.8%)

57 (56.4%)

Breslow’s depth (mm)

 Mean ± SD

0.68 ± 0.23

8.52 ± 9.75

 

4.89 ± 8.12

 Range

0.29–1.00

4.00–60.00

 

0.29–60.00

Relapse

 Yes

4 (4.0%)

20 (19.8%)

30 (29.7%)

54 (53.5%)

 No

26 (25.7%)

14 (13.9%)

1 (1.0%)

41 (40.6%)

 Spread at diagnosis

0 (0.0%)

1 (1.0%)

3 (3.0%)

4 (40.6%)

 Missing

1 (1.0%)

1 (1.0%)

0 (0.0%)

2 (2.0%)

Anatomic site of primary melanoma

 Head and neck

9 (8.9%)

9 (8.9%)

6 (5.9%)

24 (23.7%)

 Trunk

4 (4.0%)

4 (4.0%)

4 (4.0%)

12 (11.9%)

 Back

7 (6.9%)

11 (10.9%)

8 (7.9%)

26 (25.7%)

 Upper limbs

7 (6.9%)

3 (3.0%)

2 (2.0%)

12 (11.9%)

 Lower limbs

4 (4.0%)

3 (3.0%)

10 (9.9%)

17 (16.8%)

 Feet

0 (0.0%)

3 (3.0%)

1 (1.0%)

4 (4.0%)

 Hands

0 (0.0%)

0 (0.0%)

0 (0.0%)

0 (0.0%)

 Fingers or toes

0 (0.0%)

3 (3.0%)

0 (0.0%)

3 (3.0%)

 Not found

0 (0.0%)

0 (0.0%)

3 (3.0%)

3 (3.0%)

Cause of death

 Malignant melanoma

1 (1.0%)

19 (18.8%)

26 (25.7%)

46 (45.5%)

 Other

7 (6.9%)

8 (7.9%)

0 (0.0%)

15 (14.8%)

 Alive

19 (18.8%)

3 (3.0%)

5 (5.0%)

27 (26.7%)

 Unknown

4 (4.0%)

6 (5.9%)

3 (3.0%)

13 (12.9%)